Obesity and reproductive disorders in women.

@article{Pasquali2003ObesityAR,
  title={Obesity and reproductive disorders in women.},
  author={Renato Pasquali and Carla Pelusi and Silvia Genghini and Mauro Cacciari and Alessandra Gambineri},
  journal={Human reproduction update},
  year={2003},
  volume={9 4},
  pages={
          359-72
        }
}
Obesity, particularly the abdominal phenotype, is associated with several reproductive disturbances. Whereas mechanisms by which obesity affect fertility are complex and still not completely understood, an important role appears to be played by the presence of a condition of functional hyperandrogenism and hyperinsulinaemia, which accompanies the insulin-resistant state. In women with the polycystic ovary syndrome, abdominal obesity may be co-responsible for the development of hyperandrogenism… 
Metabolic effects of obesity on reproduction.
TLDR
Obese women are characterized by similar comorbidities to men, particularly type 2 diabetes mellitus and cardiovascular diseases, and insulin excess, which accompanies insulin resistance represents one of the major factors leading to altered ovarian physiology and associated ovulatory disturbances.
Obesity, fat distribution and infertility.
TLDR
Weight loss can improve hormonal abnormalities and fertility rates in both women and men and can also be improved by lifestyle intervention strategies favouring weight loss.
Obesity and infertility
TLDR
Much more attention should be paid to the impact of obesity on fertility in both women and men, and treatment of obesity may improve androgen imbalance and erectile dysfunction, the major causes of infertility in obese men.
Review article: The impact of obesity on reproduction in women with polycystic ovary syndrome
TLDR
The increasing prevalence of obesity among adolescent and young women with PCOS may partly depend on the increasing worldwide epidemic of obesity, although this hypothesis should be supported by long‐term prospective epidemiological trials.
Review Article: Obesity and Infertility
TLDR
Weight-loss lifestyle programs should be considered an ovulation induction therapy, with due consideration for a possible pregnancy in an obese woman.
Obesity as disruptor of the female fertility
TLDR
On the contrary, weight loss programs through lifestyle modification in obese women, have been proven to restore menstrual cyclicity and ovulation and improve the likelihood of conception.
Nutrition and reproduction in women.
TLDR
Management of anovulation with obesity involves diet and exercise as well as standard approaches to ovulation induction, and the fear of weight gain affects uptake and continuation of hormonal contraceptives, although existing trials indicate that any such effects are small.
Polycystic Ovary Syndrome, Obesity and Reproductive Implications
TLDR
It is an important challenge to develop effective lifestyle programs and adjuvant pharmacologic treatments in order to improve reproductive and metabolic health among women with PCOS.
Mechanisms and Treatment of Obesity in Polycystic Ovary Syndrome
TLDR
The long story of metformin in PCOS seems to demonstrate that by reducing insulin a great benefit can be achieved regardless of minor changes in body weight, which represents excellent opportunities for future research in the field of PCOS.
PREVALENCE AND RISK FACTOR OF POLYCYSTIC OVARIAN SYNDROME
TLDR
Education about how PCOS affects long-term health should be provided to women with this disorder to feel physical and psychological benefits so that they could engage themselves more with their health care providers.
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 249 REFERENCES
The impact of obesity on hyperandrogenism and polycystic ovary syndrome in premenopausal women *
TLDR
The most exciting discovery has been that hyperinsulinaemia and insulin resistance are significantly correlated with hyperandrogenism in PCOS women and that insulin may be an important factor in the regulation of ovarian steroidogenesis both in uitro and in uivo.
Treatment of the polycystic ovary syndrome with lifestyle intervention
TLDR
Weight loss should represent the first-line approach in the treatment of women with PCOS, because it significantly improves hormonal and metabolic abnormalities and may favor spontaneous ovulation and improve fertility rate in most of them.
Choice of stimulation in polycystic ovarian syndrome: the influence of obesity.
TLDR
The first stage in the optimal management of obese PCOS anovulatory women is a weight loss programme, which helps to correct the clinical and endocrine abnormalities.
Treatment of polycystic ovary syndrome with insulin-lowering agents
TLDR
Improved pregnancy outcomes in women with PCOS receiving metformin may be attributed to its ability to reduce insulin resistance, hyperinsulinaemia and hypofibrinolytic plasminogen activator inhibitor activity by the enhancement of folliculogenesis and improvement of oocyte quality.
Obesity and reproductive disorders: a review.
TLDR
Results indicate that fertility is improved through exercise and sensible eating patterns when conducted in a group environment, and the mechanisms for this are unclear but may be associated with changes in sensitivity to insulin.
Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.
TLDR
It is concluded that lifestyle modification without rapid weight loss leads to a reduction of central fat and improved insulin sensitivity, which restores ovulation in overweight infertile women with PCOS.
Reproductive endocrinologic alterations in female asymptomatic obesity.
  • R. Azziz
  • Biology, Medicine
    Fertility and sterility
  • 1989
TLDR
Evidence of alteration(s) in adrenocortical steroidogenesis has been presented suggesting a selective obesity-related enhancement in adrenal androgen secretion, which may arise secondary to the influence of other circulating and intra-adrenal factors.
Developmental origin of polycystic ovary syndrome - a hypothesis.
TLDR
It is proposed that the clinical and biochemical features of PCOS can arise as a consequence of genetically determined hypersecretion of androgens by the ovary during, or very likely long before, puberty, and a unifying, 'linear' model is suggested to explain the aetiology of the heterogeneous phenotype.
[Effects of metformin on insulin resistance and on ovarian steroidogenesis in women with polycystic ovary syndrome].
TLDR
The reduction of insulinemia seems to be actually associated with a reduction of circulating androgens in women with polycystic ovary syndrome.
Insulin sensitivity and antiandrogenic therapy in women with polycystic ovary syndrome.
TLDR
In both lean and obese PCO women, treatment with flutamide for 1 or 3 months markedly improved the clinical and biochemical androgenic features, but did not significantly influence the overall insulin sensitivity, indicating that PCO and obesity exert synergistic effects on insulin resistance.
...
1
2
3
4
5
...